Express delivery and free returns within 21 days

Thursday, July 7, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

spot_img

Diabetes Care

Ryan Reed to Compete for GMS Racing at Darlington Raceway

A new partner in NASCAR, Tandem Diabetes Care is dedicated to making the lives of people with diabetes better through relentless innovation and revolutionary customer experience.

Tandem Diabetes Care Reports Health Canada Approval of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology

Tandem Diabetes Care notes all in-warranty t:slim X2 pump users in Canada will have the option to add Control-IQ technology to their existing pump beginning in March 2021 via remote software update.

Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement

Cross-licensing each other’s patent portfolios enables both companies to focus on helping people with diabetes through innovation of future products and services, while avoiding the distraction of potential legal disagreements.

Tandem Diabetes Care Announces Expanded Pediatric Indication of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology

“Nearly 40,000 t:slim X2 users have updated their pump with our revolutionary Control-IQ technology,” said John Sheridan, president and CEO of Tandem Diabetes Care.

FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller Announced by Tandem Diabetes Care

The company reports this is the second system to receive iAGC designation by the FDA, following the Company’s clearance of the t:slim X2™ insulin pump with Control-IQ™ technology in December 2019.